|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
2R44CA119565-02
|
$381,938
|
$381,938
|
Han, James
|
AMBERGEN, INC
|
|
Molecular Test for Inherited Mutations in Breast Cancer
|
5R44CA110403-03
|
$463,209
|
$463,209
|
Lim, Mark
|
AMBERGEN, INC
|
|
Bead-array for rapid risk-stratification in leukemia
|
5R44CA115129-04
|
$465,644
|
$465,644
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
A Hypersensitive ERa Mutant in Breast Cancer Progression
|
5R01CA072038-10
|
$285,759
|
$57,152
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Prostate Cancer
|
3P50CA058204-13S1
|
$1,124,001
|
$674,401
|
ITTMANN, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Profile-Based Prognostic Markers for Ependymoma
|
5R33CA097874-05
|
$528,774
|
$528,774
|
Lau, Ching
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-25
|
$2,383,667
|
$1,191,834
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$135,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$10,053
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of AIB3 in Mammary Gland and Breast Cancer
|
5R01CA119689-03
|
$280,899
|
$280,899
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Biology and Diagnosis of HNPCC
|
5R01CA072851-12
|
$326,412
|
$326,412
|
BOLAND, Clement
|
BAYLOR RESEARCH INSTITUTE
|
|
Pyrophosphorolysis-activatable helicase dependent amplification assay for lung ca
|
1R43CA128777-01
|
$141,267
|
$141,267
|
LEMIEUX, BERTRAND
|
BIOHELIX CORPORATION
|
|
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) EXPANSION PROGRAM
|
N01PC544002-007
|
$1,756,938
|
$439,235
|
CHEN, VIVIEN
|
BOARD OF SUPERVISORS OF LA STATE UNIV
|
|
VHL, Jade-1 and protein stability in renal cancer
|
5R01CA079830-08
|
$305,314
|
$305,314
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Genome Wide Association Study: Variants Influencing Steroid Hormone Levels
|
1R03CA128034-01A1
|
$87,500
|
$87,500
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mitochondrial Haplogroups and Breast Cancer Risk
|
1R03CA130050-01
|
$87,500
|
$87,500
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-04S1
|
$87,500
|
$43,750
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
5P50CA105009-04
|
$2,278,757
|
$1,139,379
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
5U01CA086381-08
|
$861,745
|
$861,745
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
p53 signatures and pelvic serous carcinoma
|
1R21CA124688-01A1
|
$171,341
|
$85,671
|
Crum, Christopher
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Telomere Length and Endometrial Cancer
|
1R03CA132190-01
|
$87,500
|
$43,750
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Susceptibility to Endometrial Cancer
|
5R01CA082838-08
|
$331,803
|
$331,803
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective Study of DNA Repair Gene Variants in Breast Cancer
|
1R01CA118447-01A1
|
$331,008
|
$331,008
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
1R03CA132175-01
|
$86,936
|
$43,468
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biochemical Markers in the nurses' Health Study Cohort
|
5R01CA049449-18
|
$1,203,783
|
$963,026
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
2R01CA065725-11A1
|
$405,093
|
$405,093
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
2U01CA098233-05
|
$1,331,791
|
$1,331,791
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-02
|
$399,509
|
$399,509
|
MICHAUD, DOMINIQUE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
1R03CA130055-01
|
$87,500
|
$87,500
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calmodulin in neoplastic transformation of breast tissue
|
5R01CA075205-08
|
$369,080
|
$184,540
|
SACKS, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genomic and proteomic analysis of prostate cancer
|
5R01CA105304-04
|
$209,928
|
$209,928
|
SADAR, MARIANNE
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Molecular Genomics of Breast Cancer
|
5R33CA112885-03
|
$555,780
|
$555,780
|
Malkhosyan, Sergei
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$135,513
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-13
|
$708,711
|
$708,711
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Web-based Family History Screening for Hereditary Breast Cancer Risk
|
1R21CA127837-01
|
$185,400
|
$185,400
|
ACHESON, LOUISE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
$51,040
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Research Network Across Health Care Systems
|
2U19CA079689-09
|
$4,204,259
|
$840,852
|
WAGNER, EDWARD
|
CENTER FOR HEALTH STUDIES
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
Clinical Correlative Studies of Neuroblastoma
|
2R01CA060104-14A1
|
$408,898
|
$408,898
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-03
|
$1,657,644
|
$1,657,644
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Cytogenetic and Molecular Studies of Human Chromosome 22
|
5R01CA039926-20
|
$353,296
|
$353,296
|
EMANUEL, BEVERLY
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$2,477
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
$4,154
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
$90,970
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
DNA methylation in cancer genomes
|
1R21CA128495-01
|
$253,500
|
$253,500
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG Methylation and Mutation
|
5R01CA084469-08
|
$293,558
|
$293,558
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Genetics of Prostate Cancer Risk & Agressiveness
|
5R01CA098683-05
|
$423,409
|
$423,409
|
Casey, Graham
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Genomic Wide Association Study of Colorectal Cancer
|
5U01CA122839-02
|
$1,830,331
|
$1,830,331
|
Casey, Graham
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
AIDS Associated Lymphoproliferative Disorders
|
4R37CA037295-24
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-03
|
$1,235,688
|
$1,235,688
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Genetic Testing for this search: $177,451,221
|